PTC Therapeutics (PTCT) revenue

Revenue · fiscal 2025
$1.73B

PTC Therapeutics (PTCT) reported revenue of $1.73B in fiscal 2025 (the year ended December 31, 2025). That is 114.5% higher than the $806.78M of fiscal 2024. Figures as of 18 Nov 2026, 10:53 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.73B
Change on fiscal 2024
+114.5%
Growth, 5 years
+35.4% a year
Growth, 10 years
+47.0% a year
Highest on record
$1.73Bfiscal 2025
Lowest on record
$25.25Mfiscal 2014
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

PTC Therapeutics revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 35.4% a year; over ten years the rate was 47.0% a year. Across the 15 fiscal years on record (2011–2025), the highest was $1.73B in fiscal 2025 and the lowest $25.25M in fiscal 2014.

History · 15 fiscal years

Revenue by fiscal year

PTC Therapeutics revenue, year by year

PTC Therapeutics (PTCT) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.73B 114.5% up
2024$806.78M 14.0% down
2023$937.82M 34.2% up
2022$698.80M 29.7% up
2021$538.59M 41.4% up
2020$380.77M 24.0% up
2019$306.98M 16.0% up
2018$264.73M 36.2% up
2017$194.39M 135.0% up
2016$82.71M 124.9% up
2015$36.77M 45.6% up
2014$25.25M 27.2% down
2013$34.70M 2.2% up
2012$33.95M 67.8% down
2011$105.41M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of PTC Therapeutics and comparable companies
CompanyRevenueFiscal year
BillionToOne BLLN$305.11M2025
Hims & Hers Health HIMS$2.35B2025
PTC Therapeutics PTCT$1.73B2025
Haemonetics HAE$1.33B2026
Concentra Group Holdings Parent CON$2.16B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTCT

PTC Therapeutics, figure by figure

PTC Therapeutics (PTCT) overview: price, valuation and scorecardAll health care companies by market value

PTC Therapeutics revenue: questions and answers

What is PTC Therapeutics's revenue?

PTC Therapeutics (PTCT) reported revenue of $1.73B in fiscal 2025 (the year ended December 31, 2025). That is 114.5% higher than the $806.78M of fiscal 2024.

What is the growth rate of PTC Therapeutics's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 35.4% a year; over ten years the rate was 47.0% a year.

What are the highest and lowest revenue figures on record for PTC Therapeutics?

Across the 15 fiscal years on record (2011–2025), the highest was $1.73B in fiscal 2025 and the lowest $25.25M in fiscal 2014.

How is PTC Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For PTC Therapeutics it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “PTC Therapeutics (PTCT) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/PTCT/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.